Skip to main content
General Medicine

Adagrasib



General

Brand Names: U.S.

  • Krazati

Indications

Use: Labeled Indications

Colorectal cancer, locally advanced or metastatic, KRAS G12C mutated: Treatment (in combination with cetuximab) of KRAS G12C–mutated ...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

START 10-DAY FREE TRIAL
Subscribe Now
©2025 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.
Enter an Access Code
Enter the code from your copy of The 5-Minute Clinical Consult or another access code to create an account.
Redeem
×